![](/img/cover-not-exists.png)
Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand
Bruchertseifer, F., Kellerbauer, A., Malmbeck, R., Morgenstern, A.Language:
english
Journal:
Journal of Labelled Compounds and Radiopharmaceuticals
DOI:
10.1002/jlcr.3792
Date:
August, 2019
File:
PDF, 638 KB
english, 2019